The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2 Markers May Help Predict Who will Progress to Sjögren’s

2 Markers May Help Predict Who will Progress to Sjögren’s

October 18, 2018 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Other studies have shown that patients with hypergammaglobulinemia and hypo­complementemia have a higher rate of developing lymphomas, so continued monitoring of these serologic markers after diagnosis of SS is also important. “In the future, hopefully new biomarkers will be identified that will facilitate and accelerate the diagnosis of SS, and future classification will likely rely on such biomarkers,” says Dr. Shiboski.

You Might Also Like
  • ACR, EULAR Approve New Classification Criteria for Primary Sjögren’s Syndrome
  • Sjögren’s Syndrome Moves into the Spotlight
  • Ultrasound of Salivary Glands May Have Role in Diagnosing Sjogren’s
Explore This Issue
October 2018
Also By This Author
  • Ron Olejko Retires from the ACR

Susan Bernstein is a freelance medical journalist based in Atlanta.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Shiboski CH, Baer AN, Shiboski SC, et al. Natural history and predictors of progression to Sjögren’s syndrome among participants of the Sjögren’s International Collaborative Clinical Alliance Registry. Arthritis Care Res (Hoboken). 2018 Feb;70(2):284–294.
  2. Maciel G, Crowson CS, Matteson EL, et al. Prevalence of primary Sjögren’s syndrome in a U.S. population-based cohort. Arthritis Care Res (Hoboken). 2017 Oct;69(10):1612–1616.
  3. Jonsson R, Bolstad AI, Brokstad KA, et al. Sjögren’s syndrome—a plethora of clinical and immunological phenotypes with a complex genetic background. Ann NY Acad Sci. 2007 Jun;1108:433–447.
  4. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: A data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012 Apr;64(4):475–487.
  5. Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international cohorts. Arthritis Rheumatol. 2017 Jan;69(1):35–45.
  6. Cartee DL, Maker S, Dalonges D, et al. Sjögren’s syndrome: Oral manifestations and treatment, a dental perspective. J Dent Hyg. 2015 Dec;89(6):365–371.

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: hypergammaglobulinemia, hypocomplementemia. Biomarkers, predictor, progression, Sjögren's syndromeIssue: October 2018

You Might Also Like:
  • ACR, EULAR Approve New Classification Criteria for Primary Sjögren’s Syndrome
  • Sjögren’s Syndrome Moves into the Spotlight
  • Ultrasound of Salivary Glands May Have Role in Diagnosing Sjogren’s
  • Sjögren’s Syndrome: Beyond Dryness

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)